![]() |
市场调查报告书
商品编码
1608867
牛市场:按应用、按最终用户、按地区Fetal Bovine Serum Market, By Application, By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, and Others), By Geography |
牛市场预计到2024年为18.6亿美元,预计到2031年将达到45.4亿美元,2024年至2031年的复合年增长率为13.6%。
分析范围 | 分析详情 | ||
---|---|---|---|
基准年 | 2023年 | 市场规模(2024年) | 18.6亿美元 |
实际资料 | 2019-2023 | 预测期 | 2024-2031 |
预测期复合年增长率(2024-2031) | 13.60% | 预计金额(2031年) | 45.4亿美元 |
牛是一种重要的细胞培养基补充品,用于科学研究和各种医疗过程。它源自于从怀孕六个月左右宰杀的怀孕牛身上收集的胎儿血液中获得的胎儿血细胞。牛(FBS) 含有多种对细胞存活、生长和增殖至关重要的生长因子、蛋白质、黏附素和维生素。对生物製药的需求不断增长以及对细胞研究的日益关注正在推动全球牛市场的成长。
全球牛市场的成长是由生物製药需求的增加和生命科学产业研究活动的活性化所推动的。生物製药生产在很大程度上依赖牛来培养和维持最佳的细胞培养条件。慢性病盛行率的不断上升推动了对开发新药的需求,这需要利用牛进行广泛的研究工作。然而,价格波动和对畜牧业动物福利实践的道德担忧可能会阻碍市场成长。此外,向无血清和无异源细胞培养基的转变为牛市场带来了挑战。然而,对个人化医疗、再生疗法和干细胞研究的日益关注预计将在预测期内提供显着的成长机会。
本报告对全球牛市场进行了详细分析,并提供了以2023年为基准年的预测期(2024-2031)的市场规模和年复合成长率(CAGR%)。
它还阐明了各个细分市场的潜在商机,并解释了该市场中有吸引力的投资提案的矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数,提供全球牛市场主要企业的概况。
主要公司包括 Merck KGaA、Thermo Fisher Scientific Inc.、HiMedia Laboratories、Bio-Techne、PAN-Biotech、Atlas Biologicals, Inc.、Rocky Mountain Biologicals、Cytiva、Sartorius AG 和 SeraCare Life Sciences。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
本报告针对该产业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过分析全球牛市场时所使用的各种策略矩阵来促进决策。
The fetal bovine serum market is estimated to be valued at USD 1.86 Bn in 2024 and is expected to reach USD 4.54 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | 1.86 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 13.60% | 2031 Value Projection: | 4.54 Bn |
Fetal bovine serum is an important cell culture media supplement used in scientific research and various medical processes. It is derived from fetal blood cells obtained from fetal blood collected from slaughtered pregnant cattle around 6 months of gestation. Fetal bovine serum (FBS) contains various growth factors, proteins, attachment factors, and vitamins essential for cell survival, growth, and proliferation. The increasing demand for biopharmaceuticals and rising focus on cell-based research is driving the growth of the fetal bovine serum market globally.
The global fetal bovine serum market growth is driven by the rising demand for biopharmaceuticals and increasing research activities in life science industries. Biopharmaceutical production heavily relies on fetal bovine serum for growing and maintaining optimal cell culture conditions. Rising prevalence of chronic diseases is propelling the demand for new drug development which requires extensive research activities utilizing fetal bovine serum. However, price fluctuations in cattle farming and ethical concerns regarding animal welfare practices could hamper the market growth. Also, a shift towards serum-free and xeno-free cell culture mediums presents challenges to the fetal bovine serum market. Nonetheless, the growing focus on personalized medicine, regenerative therapies, and stem cell research are expected to present significant growth opportunities over the forecast period.
This report provides in-depth analysis of the global fetal bovine serum market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global fetal bovine serum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., HiMedia Laboratories, Bio-Techne, PAN-Biotech, Atlas Biologicals, Inc., Rocky Mountain Biologicals, Cytiva, Sartorius AG, and SeraCare Life Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global fetal bovine serum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fetal bovine serum market